构建多元化合作模式 和铂医药-阿斯利康北京创新实验室揭牌

新京报
Oct 28, 2025

10月25日,和铂医药-阿斯利康创新实验室在北京正式揭牌,和铂医药北京创新中心同步揭牌。  据了解,截至目前,和铂医药的抗体技术平台已与阿斯利康、辉瑞、大冢、艾伯维、莫德纳等多家跨国药企达成合作,累计总金额超百亿美元,并获得阿斯利康溢价入股,以及新加坡政府投资公司(GIC)增持股份至7.05%。  其中,今年3月,和铂医药与阿斯利康达成全球战略合作,共同研发针对免疫性疾病、肿瘤及其他多种疾病的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10